Universe Pharmaceuticals closes acquisition of Best Praise International Limited, issues 4,376,552 shares
UPC•Acquisition completed and shares issued
Universe Pharmaceuticals completed its purchase of Best Praise International on June 30, 2026, acquiring 100% of the issued shares.
Deal consideration was paid in 4,376,552 restricted Class A ordinary shares issued to the recipients.
Best Praise holds five China patents tied to pharmaceutical compounds and drug-delivery technologies, including age-related and neurodegenerative diseases.
Post-issuance share count totals 5,008,313 Class A ordinary shares and 16,077 Class B ordinary shares outstanding.
